628 studies found for:    Alexander Disease
Show Display Options
Rank Status Study
21 Unknown  Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)
Condition: Posttraumatic Stress Disorder
Intervention: Drug: Paliperidone
22 Unknown  Neuroimmunological Model of Traumatic Memory
Condition: Stress Disorders, Post-Traumatic
Intervention: Procedure: Blood test
23 Terminated Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
24 Recruiting Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Conditions: Cutaneous Lymphoma;   Other Skin Disorders;   Mycosis Fungoides;   Cutaneous T-cell Lymphoma
Intervention:
25 Completed Phase II Study With CC-10004 in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: CC-10004;   Drug: Matching Placebo
26 Not yet recruiting PACT for Individuals With Serious Mental Illness
Condition: Schizophrenia and Disorders With Psychotic Feature
Intervention: Other: Patient Aligned Care Team (PACT)
27 Completed Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate );   Drug: Antidepressant + Placebo
28 Not yet recruiting Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
Conditions: HIV;   HIV-associated Neurocognitive Disorder;   Neurotoxicity
Intervention: Drug: switch efavirenz (EFV) to raltegravir (RAL)
29 Completed Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: SPD489 (Lisdexamfetamine dimesylate );   Drug: Placebo
30 Recruiting Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS
Conditions: Traumatic Brain Injury;   Post-Traumatic Stress Disorder
Interventions: Behavioral: Experimental - COMPASS;   Behavioral: Control - COMPASS
31 Terminated
Has Results
One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
Condition: Bipolar Disorder
Intervention: Drug: Ziprasidone HCL (oral)
32 Completed Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
Conditions: Major Depressive Disorder;   Anxiety
Intervention: Drug: BCI-540
33 Recruiting Levetiracetam for Alzheimer's Disease-Associated Epileptiform Activity
Condition: Early-onset Alzheimer's Disease
Intervention: Drug: levetiracetam
34 Terminated SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
Condition: Major Depressive Disorder
Intervention: Drug: SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
35 Withdrawn Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
Conditions: Chronic Kidney Disease;   Anemia
Intervention: Drug: Rilonacept
36 Recruiting A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
Conditions: Cardiovascular Disease;   High Cardiovascular Risk;   Obesity;   Overweight;   Type 2 Diabetes
Interventions: Drug: APD356-Lorcaserin hydrochloride;   Drug: Placebo
37 Completed A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI’s, and SNRI’s Treatment in Major Depression With Anxiety
Condition: Major Depression With Comorbid Anxiety Symptoms
Intervention: Drug: Quetiapine Fumarate (Seroquel®)
38 Completed
Has Results
A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease
Condition: Congenital Heart Disease
Interventions: Biological: Motavizumab;   Biological: Palivizumab
39 Active, not recruiting A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
Condition: Peripheral Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
40 Completed Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Desvenlafaxine Succinate

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years